Ipratropium Bromide and Albuterol Sulfate 2.5 mg/3mL, .5 mg/3mL SOLUTION
Sun Pharmaceutical Industries, Inc.
FDA Drug Information
Indications & Usage
INDICATIONS AND USAGE Ipratropium bromide and albuterol sulfate inhalation solution is indicated for the treatment of bronchospasm associated with COPD in patients requiring more than one bronchodilator.
Important Warnings
WARNINGS Paradoxical Bronchospasm : In the clinical study of ipratropium bromide and albuterol sulfate, paradoxical bronchospasm was not observed. However, paradoxical bronchospasm has been observed with both inhaled ipratropium bromide and albuterol products and can be life-threatening. If this occurs, ipratropium bromide and albuterol sulfate should be discontinued immediately and alternative th…
Source: FDA. For professional use only. Not a substitute for prescribing information.
Other Ipratropium Bromide and Albuterol Sulfate NDC Codes
Wholesale and compliance resources
Order NDC 47335-0756-52 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).